Find Cannabigerol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 25654-31-3, 2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol, Chembl497318, Chebi:69477, Cannabigerol (cbg), J1k406072n
Molecular Formula
C21H32O2
Molecular Weight
316.5  g/mol
InChI Key
QXACEHWTBCFNSA-SFQUDFHCSA-N
FDA UNII
J1K406072N

Cannabigerol
cannabigerol is a natural product found in Cannabis sativa and Helichrysum umbraculigerum with data available.
1 2D Structure

Cannabigerol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol
2.1.2 InChI
InChI=1S/C21H32O2/c1-5-6-7-11-18-14-20(22)19(21(23)15-18)13-12-17(4)10-8-9-16(2)3/h9,12,14-15,22-23H,5-8,10-11,13H2,1-4H3/b17-12+
2.1.3 InChI Key
QXACEHWTBCFNSA-SFQUDFHCSA-N
2.1.4 Canonical SMILES
CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O
2.1.5 Isomeric SMILES
CCCCCC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O
2.2 Other Identifiers
2.2.1 UNII
J1K406072N
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 25654-31-3

2. 2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol

3. Chembl497318

4. Chebi:69477

5. Cannabigerol (cbg)

6. J1k406072n

7. 2808-33-5

8. Cbg

9. 1,3-benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (e)-

10. Geranylolivetol

11. Unii-j1k406072n

12. Schembl144819

13. Schembl14764730

14. Gtpl11094

15. Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-

16. Dtxsid701014168

17. (e)-2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol

18. 1,3-benzenediol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-

19. Bcp23754

20. Ex-a5335

21. Zinc4217650

22. Bdbm50318487

23. Akos024457386

24. Db14734

25. Cannabigerol (1.0 Mg/ml In Methanol)

26. C20219

27. Cannabigerol (cbg) 100 Microg/ml In Methanol

28. F70893

29. Cannabigerol (cbg) 1000 Microg/ml In Methanol

30. Cannabigerol (cbg) 250 Microg/ml In Acetonitrile

31. Q412122

32. 2-(3,7-dimethyl-2,6-octadienyl)-5-pentylresorcinol

33. (e)-2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-resorcinol

34. 2-[(2e)-3,7-dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol

35. 2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-pentyl-benzene-1,3-diol

36. (e)-2-(3,7-dimethylocta-2,6-dien-1-yl)-5-pentylbenzene-1,3-diol

37. 2-[(2e)-3,7-dimethyl-2,6-octadienyl]-5-pentyl-1,3-benzenediol #

38. 2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-pentylbenzene-1,3-diol

39. Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, (e)-

40. 1,3-benzenediol, 2-((2e)-3,7-dimethyl-2,6-octadien-1-yl)-5-pentyl-

41. Cannabigerol Solution, 1.0 Mg/ml In Methanol, Ampule Of 1 Ml, Certified Reference Material

2.4 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 316.5 g/mol
Molecular Formula C21H32O2
XLogP37.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count9
Exact Mass316.240230259 g/mol
Monoisotopic Mass316.240230259 g/mol
Topological Polar Surface Area40.5 Ų
Heavy Atom Count23
Formal Charge0
Complexity367
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Listed Suppliers

read-more
read-more

01

arrow
ASPEN
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

Flag U.S.A
Digital Content Digital Content

Cannabigerol

About the Company : Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout...

Transo-Pharm, a fully licensed and certified distributor, specializes in pharmaceutical components for the health and veterinary industries. It offers support to clients throughout the entire API life cycle, from product development through sales. Transo-Pharm serves as a sourcing and regulatory marketing agent for API manufacturers. It aids clients in establishing DMFs and provides GMP consulting. With a dedicated regulatory department, a warehouse, proprietary IPs for API processes, and partnerships with laboratories, Transo-Pharm offers a wide range of services. It operates from its offices in Shanghai, Hong Kong, Singapore, and the US.
Transo Pharm USA Company Banner

02

Amyris

U.S.A
ASPEN
Not Confirmed
arrow

Amyris

U.S.A
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : We were founded a decade ago with a vision to make the best products available to all and to help humanity while we do it. From plant-sugars to anti-malarial drugs, our proprietary...

We were founded a decade ago with a vision to make the best products available to all and to help humanity while we do it. From plant-sugars to anti-malarial drugs, our proprietary process of engineering organisms (yeast) uses renewably-sourced carbon from plants to make sustainable, custom molecules that allow our customers to make better, more effective products that are better for people and better for the planet. No Compromise.® We believe highly-engineered organisms and sustainably sourced sugarcane can help solve world problems and support a healthier planet.
blank

03

Celadon Pharmaceuticals

United Kingdom
ASPEN
Not Confirmed
arrow

Celadon Pharmaceuticals

United Kingdom
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : Celadon Pharmaceuticals is a UK-based company specializing in the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines. Their primary focus is on...

Celadon Pharmaceuticals is a UK-based company specializing in the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines. Their primary focus is on improving the quality of life for chronic pain sufferers and exploring treatments for conditions such as autism. Operating a 100,000 sq ft EU-GMP standard facility, Celadon integrates indoor hydroponic cultivation, proprietary GMP extraction, manufacturing, and an analytical R&D laboratory. Their subsidiary conducts an MHRA-approved clinical trial using cannabis-based medicinal products.
blank

04

Celadon Pharmaceuticals

United Kingdom
ASPEN
Not Confirmed
arrow

Celadon Pharmaceuticals

United Kingdom
arrow
ASPEN
Not Confirmed

Cannabigerolic Acid

About the Company : Celadon Pharmaceuticals is a UK-based company specializing in the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines. Their primary focus is on...

Celadon Pharmaceuticals is a UK-based company specializing in the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines. Their primary focus is on improving the quality of life for chronic pain sufferers and exploring treatments for conditions such as autism. Operating a 100,000 sq ft EU-GMP standard facility, Celadon integrates indoor hydroponic cultivation, proprietary GMP extraction, manufacturing, and an analytical R&D laboratory. Their subsidiary conducts an MHRA-approved clinical trial using cannabis-based medicinal products.
blank

05

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biot...

At Embio, technology is the foundation of our success, driving leadership in every product we manufacture. With 30+ years of expertise in bacterial, fungal, and Category 1 GMO biotransformation, we develop fully backward-integrated platforms, creating a first-mover advantage in global markets. A leading manufacturer of Schedule-1 and Schedule-2 substances, Embio excels in controlled substances, intermediates, and chiral molecules. Our US-FDA, PMDA, KFDA, COFEPRIS, and WHO-GMP-approved facility in MIDC Mahad serves 70+ countries, including top 10 pharma companies.
blank

06

Hempsana

Canada
ASPEN
Not Confirmed
arrow

Hempsana

Canada
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : Founded in 2018, Hempsana was borne out of the founders’ primary mission to provide comfort from ailments, and to be a part of the healing process, by providing a natural and con...

Founded in 2018, Hempsana was borne out of the founders’ primary mission to provide comfort from ailments, and to be a part of the healing process, by providing a natural and consistent high-quality product that is safe for consumers. This was put into practice by engineering an EU-GMP and GPP compliant facility that incorporates strict quality controls, exacting standards and extensive in-process testing. Through our wholesale and white-labelling platforms, we process, formulate and manufacture products to the global cannabis market which must meet our ‘Gold Standard’ for quality.
blank

07

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : MediPharm Labs is a full-service pharmaceutical company that specializes in producing and manufacturing high-quality, purified cannabinoid-based derivatives and pharmaceutical ingr...

MediPharm Labs is a full-service pharmaceutical company that specializes in producing and manufacturing high-quality, purified cannabinoid-based derivatives and pharmaceutical ingredients. It offers bulk wholesale products from its GMP-certified facilities that are equipped with ISO-standard cleanrooms and critical environments. MediPharm Labs has obtained the first-of-its-kind Drug Establishment License in North America and has international commercial distribution capabilities. Working to internationally recognized standards, it provides top cannabis products that are pure, trusted, and precisely dosable for patients and end consumers.
blank

08

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : NINGBO INNO PHARMCHEM CO.,LTD. develop, pilot and commercial produce organic chemicals, pharmaceutical intermediates and nutraceuticals. We also offer custom synthesis and manufact...

blank

09

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : Phytoplant Research S.L. is a privately-owned Spanish company founded in 2008 and active in the field of phytotherapy research. The company specializes in developing the industria...

Phytoplant Research S.L. is a privately-owned Spanish company founded in 2008 and active in the field of phytotherapy research. The company specializes in developing the industrial chain of medicinal plants, from selection and breeding to registration (for example, at CPVO), cultivation of registered varieties and obtaining derived products. Phytoplant Research S.L. focuses on research and development products that contain plant material and extracts, as well as essential and seed oils. These products represent significant economic potential for the pharmaceutical, nutraceutical and dermocosmetic industries.
blank

10

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Cannabigerol

About the Company : We are an elite team of scientists and business leaders pioneering how synthetic biology can bring the best of nature’s ingredients to market. Willow Biosciences is a biotechnolo...

We are an elite team of scientists and business leaders pioneering how synthetic biology can bring the best of nature’s ingredients to market. Willow Biosciences is a biotechnology company focused on revolutionizing industrial manufacturing of high value molecules that have traditionally been derived from plants.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

The company will use the proceeds for developing its proprietary formulations and pharmaceutical pipeline including, RHO Phyto having diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids.


Lead Product(s): Cannabidiol,Cannabigerol,Tetrahydrocannabinol

Therapeutic Area: Neurology Brand Name: RHO Phyto

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Undisclosed

Deal Size: $0.8 million Upfront Cash: Undisclosed

Deal Type: Private Placement December 04, 2023

blank

01

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Details : The company will use the proceeds for developing its proprietary formulations and pharmaceutical pipeline including, RHO Phyto having diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying r...

Product Name : RHO Phyto

Product Type : Small molecule

Upfront Cash : Undisclosed

December 04, 2023

blank

Details:

The company will use the proceeds for developing its proprietary formulations and pharmaceutical pipeline including, RHO Phyto having diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids.


Lead Product(s): Cannabidiol,Cannabigerol,Tetrahydrocannabinol

Therapeutic Area: Neurology Brand Name: RHO Phyto

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Undisclosed

Deal Size: $1.4 million Upfront Cash: Undisclosed

Deal Type: Private Placement August 02, 2023

blank

02

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Details : The company will use the proceeds for developing its proprietary formulations and pharmaceutical pipeline including, RHO Phyto having diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying r...

Product Name : RHO Phyto

Product Type : Small molecule

Upfront Cash : Undisclosed

August 02, 2023

blank

Details:

The collaboration aims to focus on Avicanna’s proprietary formulations and pharmaceutical pipeline including, RHO Phyto having diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids.


Lead Product(s): Cannabidiol,Cannabigerol,Tetrahydrocannabinol

Therapeutic Area: Neurology Brand Name: RHO Phyto

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Applied Research Centre at Langara College

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration June 13, 2023

blank

03

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Details : The collaboration aims to focus on Avicanna’s proprietary formulations and pharmaceutical pipeline including, RHO Phyto having diverse range of proprietary formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios...

Product Name : RHO Phyto

Product Type : Small molecule

Upfront Cash : Undisclosed

June 13, 2023

blank

Details:

Through the license and supply agreement, the South American pharmaceutical company will license Avicanna’s intellectual property and supply finished pharmaceutical products starting initially with its proprietary 10% cannabidiol oral preparation, marketed under the RHO Phyto.


Lead Product(s): Cannabidiol,Tetrahydrocannabinol,Cannabigerol

Therapeutic Area: Neurology Brand Name: Rho Phyto

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Undisclosed

Deal Size: $1.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement April 13, 2022

blank

04

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Avicanna

Canada
arrow
ASPEN
Not Confirmed

Details : Through the license and supply agreement, the South American pharmaceutical company will license Avicanna’s intellectual property and supply finished pharmaceutical products starting initially with its proprietary 10% cannabidiol oral preparation, mark...

Product Name : Rho Phyto

Product Type : Small molecule

Upfront Cash : Undisclosed

April 13, 2022

blank

Details:

New CBG products include Advanced Formula, which is a CBG:CBD 1:2 oil, and Northbound, which is a high CBG vape cartridge with CBD inspired by The White and Appalachia strains.


Lead Product(s): Cannabigerol,Cannabidiol

Therapeutic Area: Neurology Brand Name: CBG:CBD

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 05, 2022

blank

05

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : New CBG products include Advanced Formula, which is a CBG:CBD 1:2 oil, and Northbound, which is a high CBG vape cartridge with CBD inspired by The White and Appalachia strains.

Product Name : CBG:CBD

Product Type : Small molecule

Upfront Cash : Not Applicable

April 05, 2022

blank

Details:

Naturally derived oil and inhalable cannabigerol (cannabinoid) products added to MediPharm's wellness portfolio – the benefits of CBG without the effects of THC.


Lead Product(s): Cannabidiol,Cannabigerol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable April 05, 2022

blank

06

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : Naturally derived oil and inhalable cannabigerol (cannabinoid) products added to MediPharm's wellness portfolio – the benefits of CBG without the effects of THC.

Product Name : Undisclosed

Product Type : Small molecule

Upfront Cash : Not Applicable

April 05, 2022

blank
  • Development Update

Details:

According to the research by Oregon state university Hemp Comound, Cannabigerolic Acid has a good safety profile in humans and are effective against variants of SARS-CoV-2 including variant.


Lead Product(s): Cannabigerol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 10, 2022

blank

07

Oregon State University

Country
arrow
ASPEN
Not Confirmed

Oregon State University

Country
arrow
ASPEN
Not Confirmed

Details : According to the research by Oregon state university Hemp Comound, Cannabigerolic Acid has a good safety profile in humans and are effective against variants of SARS-CoV-2 including variant.

Product Name : Undisclosed

Product Type : Small molecule

Upfront Cash : Not Applicable

January 10, 2022

blank

Details:

HUM-234 was shown to prevent weight gain in mice fed a high fat diet, and importantly abrogated the development of fatty liver (steatosis), a condition clinically associated with multiple metabolic disorders, including diabetes and obesity and a precursor to liver fibrosis.


Lead Product(s): Cannabigerol

Therapeutic Area: Neurology Brand Name: HUM-234

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 26, 2021

blank

08

ASPEN
Not Confirmed
ASPEN
Not Confirmed

Details : HUM-234 was shown to prevent weight gain in mice fed a high fat diet, and importantly abrogated the development of fatty liver (steatosis), a condition clinically associated with multiple metabolic disorders, including diabetes and obesity and a precurso...

Product Name : HUM-234

Product Type : Small molecule

Upfront Cash : Not Applicable

October 26, 2021

blank

Details:

The programs include in-vitro study of thin film delivery of cannabigerol and quercetin for potential anti-bacterial and anti-viral treatments as well as development of point-of-care sensor-film.


Lead Product(s): Cannabigerol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: PreclinicalProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 03, 2020

blank

09

XPhyto

Canada
arrow
ASPEN
Not Confirmed

XPhyto

Canada
arrow
ASPEN
Not Confirmed

Details : The programs include in-vitro study of thin film delivery of cannabigerol and quercetin for potential anti-bacterial and anti-viral treatments as well as development of point-of-care sensor-film.

Product Name : Undisclosed

Product Type : Small molecule

Upfront Cash : Not Applicable

March 03, 2020

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Cronos Group

Canada
ASPEN
Not Confirmed
arrow

Cronos Group

Canada
arrow
ASPEN
Not Confirmed

Cannabigerol

Brand Name :

Dosage Form : Sweet Gummy

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Canada

blank

01

Cronos Group

Canada
ASPEN
Not Confirmed
arrow

Cronos Group

Canada
arrow
ASPEN
Not Confirmed

Cannabigerol

Dosage : Sweet Gummy

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Canada

blank

02

Geocann

U.S.A
ASPEN
Not Confirmed
arrow

Geocann

U.S.A
arrow
ASPEN
Not Confirmed

Cannabigerol

Brand Name : VESIsorb

Dosage Form : Softgel

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : U.S.A

blank

02

Geocann

U.S.A
ASPEN
Not Confirmed
arrow

Geocann

U.S.A
arrow
ASPEN
Not Confirmed

Cannabigerol

Dosage : Softgel

Dosage Strength :

Brand Name : VESIsorb

Approval Date :

Application Number :

Registration Country : U.S.A

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 25654-31-3 / Cannabigerol API manufacturers, exporters & distributors?

Cannabigerol manufacturers, exporters & distributors 1

94

PharmaCompass offers a list of Cannabigerol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cannabigerol manufacturer or Cannabigerol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cannabigerol manufacturer or Cannabigerol supplier.

PharmaCompass also assists you with knowing the Cannabigerol API Price utilized in the formulation of products. Cannabigerol API Price is not always fixed or binding as the Cannabigerol Price is obtained through a variety of data sources. The Cannabigerol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cannabigerol

Synonyms

25654-31-3, 2-[(2e)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol, Chembl497318, Chebi:69477, Cannabigerol (cbg), J1k406072n

Cas Number

25654-31-3

Unique Ingredient Identifier (UNII)

J1K406072N

About Cannabigerol

cannabigerol is a natural product found in Cannabis sativa and Helichrysum umbraculigerum with data available.

Cannabigerol Manufacturers

A Cannabigerol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cannabigerol, including repackagers and relabelers. The FDA regulates Cannabigerol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cannabigerol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cannabigerol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cannabigerol Suppliers

A Cannabigerol supplier is an individual or a company that provides Cannabigerol active pharmaceutical ingredient (API) or Cannabigerol finished formulations upon request. The Cannabigerol suppliers may include Cannabigerol API manufacturers, exporters, distributors and traders.

click here to find a list of Cannabigerol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cannabigerol GMP

Cannabigerol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Cannabigerol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cannabigerol GMP manufacturer or Cannabigerol GMP API supplier for your needs.

Cannabigerol CoA

A Cannabigerol CoA (Certificate of Analysis) is a formal document that attests to Cannabigerol's compliance with Cannabigerol specifications and serves as a tool for batch-level quality control.

Cannabigerol CoA mostly includes findings from lab analyses of a specific batch. For each Cannabigerol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Cannabigerol may be tested according to a variety of international standards, such as European Pharmacopoeia (Cannabigerol EP), Cannabigerol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cannabigerol USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty